Skip to main content
Fig. 12 | BMC Cancer

Fig. 12

From: Comprehensive network pharmacology and experimentation to unveil the therapeutic efficacy and mechanisms of gypenoside LI in anaplastic thyroid cancer

Fig. 12

Gyp LI enhances the sensitivity of ATC cells to radioactive iodine. (A-B) Relative mRNA expression levels of TSHR and NIS in 8305 C and C643 cells from the control and Gyp LI-treated groups, as assessed by real-time quantitative PCR. (C-F) Western blot analysis of 8305 C and C643 cells treated with Gyp LI. Alterations in NIS protein expression were observed in the cell lysates, with GAPDH used as a loading control

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us